Ctxr stock forecast 2025

Stock Price Forecast. The 3 analysts offering 12-month price foreca

Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on 6 Wall Street analysts offering 12 month price targets for Vor Biopharma in the last 3 months. The average price target is $15.75 with a high forecast of $22.00 and a low forecast of $10.00. The average price target represents a 650.00% change from the last price of $2.10. Highest Price Target $22.00. Average Price Target $15.75.

Did you know?

Target values for the price of one Clover Health Investments share for Aug 2025. The weighted average target price per Clover Health Investments share in Aug 2025 is: 2.65. In Aug, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 9.803% volatility is expected. Pessimistic target level: 2.52.28 Wall Street research analysts have issued twelve-month price objectives for Advanced Micro Devices' shares. Their AMD share price forecasts range from $80.00 to $200.00. On average, they expect the company's share price to reach $137.03 in the next year. This suggests a possible upside of 25.7% from the stock's current price.Citius Pharmaceuticals Inc's trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.190 per share for the current fiscal year. Citius Pharmaceuticals Inc does not currently pay a dividend.The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.19% during the next 3 months and, with a 90% probability hold a price between $0.722 and $1.26 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or ...Find real-time SPIR - Spire Global Inc stock quotes, company profile, news and forecasts from CNN Business.US17322U2078. Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite.Moderna Inc () Stock Market info Recommendations: Buy or sell Moderna stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Moderna share forecasts, stock quote and buy / sell signals below.According to present data Moderna's MRNA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Navidea Biopharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Navidea Biopharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Navidea Biopharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Navidea Biopharmaceuticals's NAVB shares and potentially its market environment have ...View Citius Pharmaceuticals, Inc CTXR investment & stock information. Get the latest Citius Pharmaceuticals, Inc CTXR detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Target values for the price of one CrowdStrike Holdings share for Nov 2025. The weighted average target price per CrowdStrike Holdings share in Nov 2025 is: 125.06. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 12.881% volatility is expected. Pessimistic target level: 119.86.The average 89bio stock price prediction forecasts a potential upside of 279.98% from the current ETNB share price of $9.78. What is ETNB's forecast return on assets (ROA) for 2023-2026? (NASDAQ: ETNB) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.A. While ratings are subjective and will change, the latest Citius Pharma ( CTXR) rating was a reiterated with a price target of $0.00 to $4.00. The current price Citius Pharma ( CTXR) is trading ...View the latest Citius Pharmaceuticals Inc. (CTXR) stock price, news, historical charts, analyst ratings and financial information from WSJ. 10/11/2023. Palantir stock price stood at $17.92. According to the latest long-term forecast, Palantir price will hit $20 by the end of 2024 and then $25 by the end of 2025. Palantir will rise to $35 within the year of 2026, $40 in 2027, $50 in 2028, $55 in 2029, $60 in 2030, $65 in 2032, $70 in 2034 and $75 in 2035.Find real-time ZOM - Zomedica Corp stock quotes, company profile, news and forecasts from CNN Business.Last Five Real-Time Trades. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly ...According to our current CELH stock forecast, the value of Celsius Holdings shares will rise by 2.59% and reach $ 170.03 per share by October 16, 2023. According to our technical indicators, the current sentiment is Bullish while the Fear & Greed Index is showing 39 (Fear).CELH stock recorded 14/30 (47%) green days with 9.09% price volatility over the last 30 days.The 1 analysts offering 12-month price forecasts for RegenETP, Inc have a median target of 0.80, with a high estimate of 0.80 and a low estimate of 0.80. The median estimate represents a +1,130.77 ...Stock Price Forecast. The 4 analysts offering 12-month price forecasts for Spire Global Inc have a median target of 26.50, with a high estimate of 32.00 and a low estimate of 20.00. The median ...CRMD Stock 12 Months Forecast. $14.33. (302.53% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Cormedix in the last 3 months. The average price target is $14.33 with a high forecast of $19.00 and a low forecast of $6.00. The average price target represents a 302.53% change from the last price of $3.56.CRMD Stock 12 Months Forecast. $14.33. (302.53% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Cormedix in the last 3 months. The average price target is $14.33 with a high forecast of $19.00 and a low forecast of $6.00. The average price target represents a 302.53% change from the last price of $3.56.The difference with mino-lok and other company products is that mino-lok is the only product available in a 1.5billion dollar market, now that doesn't mean it'll capture 100% of the market, however because its the only product itll capture the most and the market cap of CTXR is around 300mil at 2$. 1.2bil = 8$ price tag and thats only the 1 ...

Find real-time CRLBF - Cresco Labs Inc stock quotes, company profile, news and forecasts from CNN Business. TG Therapeutics Stock Forecast 2023. $19.00. In the last five quarters, TG Therapeutics's Price Target has fallen from $290.38 to $73.38 - a -74.73% decrease. One analysts predict that TG Therapeutics's share price will fall in the coming year, reaching $19.00. This would represent a decrease of -74.11%.The average Viatris stock price prediction forecasts a potential upside of 9.45% from the current VTRS share price of $10.05. What is VTRS's forecast return on assets (ROA) for 2023-2026? (NASDAQ: VTRS) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.05%.Target values for the price of one Coupang share for Oct 2025. The weighted average target price per Coupang share in Oct 2025 is: 17.82. In Oct, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 9.593% volatility is expected. Pessimistic target level: 16.63. Optimistic target level: 18.39.BioNTech SE - ADR () Stock Market info Recommendations: Buy or sell BioNTech SE - ADR stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the BioNTech SE - ADR share forecasts, stock quote and buy / sell signals below.According to present data BioNTech SE - ADR's BNTX shares and potentially its market environment have been in bearish cycle last 12 months ...

Let's dig deeper into the top AI stocks that should help unlock the growing AI millionaire opportunity. MSFT Microsoft $308.14 GOOG Alphabet $107.82 NVDA NVIDIA $287.52 META Meta Platforms $235. ...Oct 5, 2023 · Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2023 Financial Results and Provides Business Update. $33.3 million in cash and cash equivalents as of June 30, 2023; runway through August 2024 CRANFORD, N.J. , Aug. 14, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasd... 6 weeks ago - PRNewsWire. ctxr stock forecast 2025 ctxr reddit ctxr price target reddit ctxr stock forecast 2022 ctxr stock future ctxr stock forecast zacks citius pharmaceuticals Popular Search Web Page Charles & Colvard Ltd. Stock Quote (U.S. - CTHR - MarketWatch…

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Recent future growth updates Aug 01 Feb 16 Nov 16 Show al. Possible cause: We would like to show you a description here but the site won’t allow us..

On April 17, 2023 at 15:10:33 ET an unusually large $25.00K block of Call contracts in Citius Pharmaceuticals (CTXR) was bought, with a strike price of $2.50 / share, expiring in 214 day(s) (on ...Surface Oncology Inc () Stock Market info Recommendations: Buy or sell Surface Oncology stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Surface Oncology share forecasts, stock quote and buy / sell signals below.According to present data Surface Oncology's SURF shares and potentially its market environment have been in a bullish cycle in the last 12 ...American Battery Metals stock surged today after the Nevada-based lithium-ion extraction and recycling company announced it had submitted its initial application to the NASDAQ to begin the process of moving its stock listing from the OTC Markets to the NASDAQ Exchange. The company is in the process of changing its name to American …

The 1 analysts offering 12-month price forecasts for RegenETP, Inc have a median target of 0.80, with a high estimate of 0.80 and a low estimate of 0.80. The median estimate represents a +1,130.77 ... CTXR Stock 12 Months Forecast. Average Price Target. $4.00 (484.45% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Citius Pharmaceuticals ... If you're looking for the data for Ctxr Stock Price Target, GetCoinTop is here to support you. We select useful information related to Ctxr Stock Price Target from reputable sites. ... The Shiba Inu Price Prediction For 2021-2025; Crypto Investment 5 Important Things You Should Know About Investing In Cardano; 6 Best Ethereum Wallets For New ...

Based on 19 Wall Street analysts offering 12 month price targ Estee Lauder , Overweight, $282, "Consensus only forecasts 3-4% revenue CAGR's vs. a pre-Covid period looking out over the next two years, seemingly too low if China fully recovers relative to ...CTXR stock complete price action . CTXR stock complete financials . CTXR stock momentum . What does the market think about CTXR stock . CTXR stock newest alerts . CTXR stock social trends . CTXR stock prediction . CTXR stock charts . CTXR stock scanner . 5000 alerts + Find Your Next CTXR Trade! CRANFORD, N.J., March 30, 2023 /PRNewswire/ -- Citius PharmThe average ACCENTURE PLC-CL A stock fore 2025: $341.70 consensus CFPS. If Amazon were to simply remain valued at the median of its operating cash flow multiple (30) over the past 11 years (the midpoint between 23 and 37), the $341.70 in ... The average Himax Technologies stock forecast 2024 represents a - Citius Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CTXR updated stock price target summary. ctxr stock forecast 2025 citius pharmaceutCitius Pharmaceuticals (CTXR) Stock Forecast, Price &amThe Wall Street analyst predicted that Citius Pharmaceuticals  CTXR 2M Long Term test Citius Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary produ test Citius Pharmaceuticals, Inc. …Find the latest Citius Pharmaceuticals, Inc. (CTXR) stock quote, history, news and other vital information to help you with your stock trading and investing. Apr 17, 2023 · The put/call ratio of CTXR is Forecasts are adjusted once a day taking into account the price change of the previous day. To date, analysts have a $54.88 target price for Citigroup stock stock. Today 200 Day Moving Average is the resistance level (47.15 $). 50 Day Moving Average is the resistance level (45.55 $). 2023. 연관검색어 : ctxr ctxr reddit ctx검사 ctxr stock ctxr 주가 ctxr twitter ctx[Citius Pharmaceuticals Inc. analyst estimates, including CTXR earniWe have a stock forecast section on every company that Medtronic Stock Forecast 2023. $86.00. In the last five quarters, Medtronic's Price Target has fallen from $140.79 to $90.05 - a -36.04% decrease. Twenty analysts predict that Medtronic's share price will fall in the coming year, reaching $86.00. This would represent a decrease of -4.5%.Corporate Overview. Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription products.